FAS mRNA levels tended to be increased in the SS group and were significantly increased in the NASH group, indicating that insulin signaling for lipogenesis is activated in NAFLD despite impaired suppression of gluconeogenetic enzymes. The gene discussed is FAS; the disease is metabolic dysfunction-associated steatohepatitis.